In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead (nytimes.com) 73
In the worldwide race for a vaccine to stop the coronavirus, the laboratory sprinting fastest is at Oxford University. From a report: Most other teams have had to start with small clinical trials of a few hundred participants to demonstrate safety. But scientists at the university's Jenner Institute had a running start on a vaccine, having proved in previous trials that similar inoculations -- including one last year against an earlier coronavirus -- were harmless to humans. That has enabled them to leap ahead and schedule tests of their new coronavirus vaccine involving more than 6,000 people by the end of next month, hoping to show not only that it is safe, but also that it works. The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September -- at least several months ahead of any of the other announced efforts -- if it proves to be effective.
Now, they have received promising news suggesting that it might. Scientists at the National Institutes of Health's Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic -- exposure that had consistently sickened other monkeys in the lab. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test. "The rhesus macaque is pretty much the closest thing we have to humans," Dr. Munster said, noting that scientists were still analyzing the result. He said he expected to share it with other scientists next week and then submit it to a peer-reviewed journal.
Now, they have received promising news suggesting that it might. Scientists at the National Institutes of Health's Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic -- exposure that had consistently sickened other monkeys in the lab. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test. "The rhesus macaque is pretty much the closest thing we have to humans," Dr. Munster said, noting that scientists were still analyzing the result. He said he expected to share it with other scientists next week and then submit it to a peer-reviewed journal.
H...time to buy stock shares? (Score:2)
Re: (Score:2)
Faster than that (Score:2)
Looks "close" means minimum 6 months
From the summary:
the first few million doses of their vaccine could be available by September
Re: (Score:2)
From the summary:
the first few million doses of their vaccine could be available by September
That will be in the UK. In the US, 18 months if we're lucky. And the same time frame would apply if the developer were a US university.
Re: (Score:2)
Re: (Score:2)
Last week, there were reports from Cleveland that remdisivir was the magic bullet that cured COVID-19. Then, the results looked murky, so waiting for more information.
Re: (Score:2)
Did you not even read the damn summary?
Re: (Score:2)
Re: (Score:1)
Re: (Score:2)
Re: (Score:2)
Re: H...time to buy stock shares? (Score:1)
Re: (Score:2)
I think it's probably accurate, just doesn't mean quite what people think. A million does is probably enough to last through phase 3 trials, with some in reserve.
Re: (Score:2)
Re: (Score:2)
Re: (Score:3)
Maybe if you have a segment in your portfolio for long shot investments. But I wouldn't put down the rent money on it.
Sprinting past an early benchmark is fine, but what matters is crossing the finish line first with a product that works in humans and can be produced in the billions of units.
Re: (Score:2)
So even if this particular vaccine doesn't work out, now is a good time to buy more stocks, unless you have good skill at timing the market.
Re: (Score:2)
I bought SPDR at $237, I'd love another panic I could take another bite now.
We've got another 2 weeks or so of Q1 news, there is no way to know if this round of rebalancing is finished.
But a second wave is likely as places reopen. Stay liquid until you see a fire sale.
Re: H...time to buy stock shares? (Score:2)
Re: (Score:2)
Re: (Score:2)
This fall there is going to be another panic--when Covid-19 comes roaring back.
Re: H...time to buy stock shares? (Score:2)
Re: (Score:2)
Re: (Score:2)
Your logic is wildly off. You're not factoring in the odds of the inoculated monkeys not getting sick at all due to deliberate exposure.
Re: (Score:2)
Well, even in the summary, they didn't claim that monkeys got sick and survived. They claimed monkeys stayed healthy.
I, for one (Score:1)
Re:I, for one (Score:5, Funny)
Welcome our covid-free monkey overlords.
So, this is how the Planet of the Apes really starts..
It's getting obvious (Score:2)
We're going to see posts about every news release made by every university research group and every company that's currently working on a coronavirus vaccine. Plus a few "rah rah my country is going to come up with the vaccine first because we're the best" posts for good measure.
Re:It's getting obvious (Score:5, Insightful)
And why shouldn't we celebrate the brilliant men and women who develop those kinds of breakthrough advances or allow people to take some national pride in it? No one bats an eye when athletes do it and at most nerds roll their eyes and mumble something about sports ball. It's even better than sports because no matter which university or which country develops a working vaccine, the whole world wins. I'll trade a little bit of semi-sufferable smugness for hundreds of thousands of lives.
Re: (Score:3)
"the author of that opinion piece teaches in a department that won't contribute anything towards finding a vaccine, or anything of value to humanity for that matter" Indeed (for those who don't follow the link), the author of that article "researches vulnerability and gender." I guess she's also invented the Oxford Apostrophe, since she writes "...questions about it’s sharing of information politically".
Re: (Score:2)
My post was intended as an observation - much like we pre-coronavirus we were seeing "here's some new whiz-bang battery tech from group A, coming Real Soon Now" followed by "even more whiz-bang battery tech from group B, coming Real Soon Now BTW we deserve tenure" seemingly every few days, we are now seeing similar news-release-driven posts about coronavirus vaccine work.
I don't particularly see the value in posting stories which don't amount to much more than regurgitated news releases.
Re: (Score:2)
Re: (Score:2)
And And, of course, the posts about how we need to do a zillion year study before we can even try it.
Re: (Score:2)
Re: (Score:2)
This one has *some* substance. But, as was said above, I wouldn't put my rent money on it. It's quite early days in the study. Even the number of macaque wasn't large enough to justify trusting it as a generally safe vaccine for macaque monkey. But it *is* promising. And that's good to hear.
Re: (Score:2)
There are some vaccines in human trials in the US also. Two for certain and I think at least one more. No idea how well the trials are going...and that's the way it's supposed to work. You don't analyze the results in the middle of the study unless something's really going wrong....or so remarkably right that you no longer need a control group.
Re: (Score:2)
Re: (Score:2)
I'm perfectly fine with competitive spirit and national pride pushing us toward the goal, as long as whomever gets there first doesn't go all EpiPen with it, or make it unavailable to other countries through nationalistic horseshit.
Finding an effective vaccine to this coronavirus would be a good thing, regardless of motivation.
Re: (Score:2)
Not yet (Score:5, Interesting)
I hope it works, but we need guarded optimism because there are a shitload of things that can go wrong .. here are a few:
1. How long does the immunity last? Does it wear off before it can be useful? It's a common problem, the vaccine design has to ensure the correct immunological pathways are activated.
2. If the person is infected with a version of the virus wherein the target protein(s) is mutated .. will the immune system go bonkers and make the old (non-neutralizing to the new strain) antibodies? (Hoskins effect)
3. Another thing that can happen is that the antibodies can actually help certain strains of the virus infect cells (Antibody dependent enhancement).
3. Can it trigger autoimmunity? (possible but very rare)
If you want references for vaccines that failed .. look up most of the dengue fever and HIV vaccine candidates that had human trials.
I am excluding the infamous 2017/2018 flu season's ineffective vaccine which resulted in a crazy high record number of deaths -- because that was caused by bad strain selection (so not really applicable here).
Re: (Score:2)
I didn't say that did I? Maybe you should get some exposure to how science works?
You're more like Donald Trump doubling down on the first good-ish sounding thing -- like bleach drinking.
Re: (Score:2)
If you want references for vaccines that failed .. look up most of the dengue fever and HIV vaccine candidates that had human trials.
It seems like Coronavirus is a lot easier to make a vaccine for than HIV....
Re: (Score:2)
Mutations (Score:1)
Re: (Score:3)
Coranavirus is an RNA virus. HIV is a DNA retrovirus. So yes, naturally, any coronavirus is going to be easier to target than HIV. RNA viruses are simpler, less sophisticated than DNA viruses.
Re: Not yet (Score:2)
Your comment is essentially false (HIV is an RNA virus too), but I dont feel like delving into the details (HIV has a smaller genome than Coronaviruses etc.) so just google it.
Re: (Score:2)
Well, we don't know that yet. But it well may be, because there were incomplete efforts at a vaccine against SARS that are acting as a springboard. OTOH, there's concern that the surface of the lungs may not be accessible to antibodies, or at least not readily accessible. And at least one source told me that what you need against viruses is not antibodies, but rather killer T-Cells. ... but certainly some of the vaccine formulations should generate those. (At least the one using inactivated viruses, eve
Re: (Score:1)
I probably won't be able to take it because of auto immune issues. But if enough healthy people can take it to build up herd immunity it could help me anyway.
STAY INSIDE - TAKE YOUR INJECTION - DON'T LOOK UP (Score:1)
Not quite right (Score:2, Interesting)
China's strength is finding deadly bat viruses, tinkering with them in a lab, then releasing them accidentally on the world.
China didn't accidentally release the virus on the world. They did it intentionally.
Think back to late January 2020. Coronavirus is exploding through Wuhan and scary videos of bodies piling up outside hospitals are going viral on Liveleak. I remember it like it was only a few months ago (well actually I suppose it *was* only a few months ago)
The Communist Party leadership finally realizes that this virus is a super serious problem, they panic, and they give the order to put the city of Wuhan on lockdown. Th
28 Days (Score:2)
Hmm... Was the 28 Days reference a twisted joke?
By the time we have a vaccine (Score:1)
By the time we have a vaccine, everyone who could be infected would already have had the disease. So this is definitely useless for COVID19 and likely for COVID20 as well. To deal with that we need to stop sabotaging therapeutics with studies that only give them to already dying patients, and therefore are designed to fail.
This might be useful for C21 though.
No:By the time we have a vaccine (Score:2)
By the time we have a vaccine, everyone who could be infected would already have had the disease.
Not hardly. I know lots of people who will be obsessive-compulsive about this thing until they are *sure* there is basic herd immunity due to the existence and broad application of a well-vetted vaccine or well-organized test-and-isolate strategy or sure knowledge that the existing virus has been stomped out.
I am more risk tolerant and look forward simply to a significant reduction in the probability that the virus is basically contained. I am in Ohio where the governor (a Republican) was surprisingly early
Re: (Score:2)
Correction to the double negative typo... "I look forward to a significant reduction in the probability of being around an active case, as would be true of the virus is basically contained."
Re: (Score:1)
For a vaccine to make sense it needs to be much safer than the disease. Remember, you will have to give it to 160M people in US alone for it to do much at all. If even a small fraction of those people has an adverse reaction, the vaccine will kill a ton of folks and will become politically infeasible. So they're going to take their time with it. 18 months might be an optimistic estimate. In fact, we might not have a vaccine for this at all in the end, just like we do not have a vaccine for another popular c
Amidst all the dim-wits, there's still brightness (Score:2)
good luck to us all (Score:2)
Test in Sweden (Score:2)
28 days ...later (Score:2)
2 - 5 Years To Get FDA Approval (Score:2)
It takes longer to gain USA Federal Government Approval (FDA, etc.) than it does to develop any medical device, vaccine, medicine.
We are years away from having a genuine vaccine for the novel coronavirus if this past timelines for approvals.
So Sorry but this all Sucks...